Financials EMVision Medical Devices Ltd

Equities

EMV

AU0000028375

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
2.15 AUD -2.27% Intraday chart for EMVision Medical Devices Ltd -3.15% +26.84%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023
Capitalization 1 21.02 85.44 216.9 116.4 91.16
Enterprise Value (EV) 1 16.63 80.03 207.4 110.4 84.23
P/E ratio -5.79 x -23.7 x -25.1 x -18.5 x -23.5 x
Yield - - - - -
Capitalization / Revenue 14.9 x 53.3 x 128 x 26.7 x 13.1 x
EV / Revenue 11.8 x 50 x 122 x 25.3 x 12.1 x
EV / EBITDA - - -24,491,755 x -18,300,219 x -22,001,134 x
EV / FCF -15,236,478 x -40,519,770 x -134,841,197 x -63,634,981 x 37,825,329 x
FCF Yield -0% -0% -0% -0% 0%
Price to Book 4.57 x 15.5 x 21.6 x 16.4 x 17.8 x
Nbr of stocks (in thousands) 57,579 63,760 72,058 77,633 77,915
Reference price 2 0.3650 1.340 3.010 1.500 1.170
Announcement Date 8/30/19 8/26/20 8/31/21 8/29/22 8/29/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.4927 1.414 1.601 1.699 4.36 6.973
EBITDA - - - -8.469 -6.032 -3.829
EBIT 1 -0.8446 -2.959 -3.512 -8.486 -6.107 -3.955
Operating Margin -171.43% -209.17% -219.3% -499.48% -140.05% -56.72%
Earnings before Tax (EBT) 1 -0.845 -2.959 -3.476 -8.399 -6.109 -3.871
Net income 1 -0.845 -2.959 -3.476 -8.399 -6.109 -3.871
Net margin -171.52% -209.23% -217.03% -494.36% -140.11% -55.51%
EPS 2 -0.0410 -0.0630 -0.0566 -0.1198 -0.0812 -0.0498
Free Cash Flow - -1.092 -1.975 -1.538 -1.735 2.227
FCF margin - -77.18% -123.33% -90.54% -39.78% 31.94%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/11/18 8/30/19 8/26/20 8/31/21 8/29/22 8/29/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 S2
Net sales 1 2.029
EBITDA 1 -2.996
EBIT 1 -0.8064
Operating Margin -39.74%
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 8/29/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.02 4.38 5.41 9.48 6.06 6.93
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -1.09 -1.98 -1.54 -1.73 2.23
ROE (net income / shareholders' equity) - -101% -68.6% -108% -71.3% -63.5%
ROA (Net income/ Total Assets) - -55.4% -39.6% -63.2% -39.6% -24.7%
Assets 1 - 5.344 8.77 13.29 15.43 15.68
Book Value Per Share 2 0.0400 0.0800 0.0900 0.1400 0.0900 0.0700
Cash Flow per Share 2 0.0300 0.0800 0.0800 0.1300 0.0900 0.1300
Capex - - - 0.13 0.19 0.19
Capex / Sales - - - 7.49% 4.38% 2.69%
Announcement Date 12/11/18 8/30/19 8/26/20 8/31/21 8/29/22 8/29/23
1AUD in Million2AUD
Estimates
  1. Stock Market
  2. Equities
  3. EMV Stock
  4. Financials EMVision Medical Devices Ltd